Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma

NCT07032129 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Multiple Myeloma in Relapse
Multiple Myeloma Progression
Multiple Myeloma, Refractory

Interventions

BIOLOGICAL: BCMA/GPRC5D CAR-T cells

Sponsor

Essen Biotech